Cfc1^b2b2736.1Clo

This ENU-induced mutation was isolated in a screen at the University of Pittsburgh. It is a subline of b2b2736Clo. The molecular lesion is a G to A substitution at nucleotide +1 after coding nucleotide 103 (c.103+1G>A, NM_007685) in intron 2, changing splice donor site A-GT to A-AT (which is assumed to be inactive or much less efficient). (J:175213) Additional incidental mutations were detected in sequencing for the causative mutation, Cfc1b2b2736.1Clo, and may be present in stocks carrying this mutation.